Compare USCB & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USCB | PRME |
|---|---|---|
| Founded | 2002 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.5M | 601.1M |
| IPO Year | 2021 | 2022 |
| Metric | USCB | PRME |
|---|---|---|
| Price | $19.27 | $4.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $22.00 | $9.31 |
| AVG Volume (30 Days) | 36.3K | ★ 3.7M |
| Earning Date | 01-22-2026 | 11-07-2025 |
| Dividend Yield | ★ 2.06% | N/A |
| EPS Growth | ★ 50.85 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $92,331,000.00 | $5,977,000.00 |
| Revenue This Year | $26.26 | $111.80 |
| Revenue Next Year | $13.21 | N/A |
| P/E Ratio | $12.37 | ★ N/A |
| Revenue Growth | 28.61 | ★ 647.13 |
| 52 Week Low | $15.39 | $1.11 |
| 52 Week High | $20.49 | $6.94 |
| Indicator | USCB | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 72.15 | 52.01 |
| Support Level | $18.39 | $3.95 |
| Resistance Level | $18.47 | $4.42 |
| Average True Range (ATR) | 0.54 | 0.30 |
| MACD | 0.11 | 0.12 |
| Stochastic Oscillator | 75.81 | 76.72 |
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.